Active 0 6 0 6 O
malignancy 7 17 7 17 B-cancer

Colchicine 0 10 18 28 B-treatment
use 11 14 29 32 O
within 15 21 33 39 O
1 22 23 40 41 B-upper_bound
month 24 29 42 47 I-upper_bound

Glomerular 0 10 48 58 B-clinical_variable
filtration 11 21 59 69 I-clinical_variable
rate 22 26 70 74 I-clinical_variable
< 27 28 75 76 O
30mL 28 32 76 80 B-upper_bound
/ 32 33 80 81 I-upper_bound
minute 33 39 81 87 I-upper_bound

High 0 4 88 92 B-clinical_variable
- 4 5 92 93 I-clinical_variable
dose 5 9 93 97 I-clinical_variable
statin 10 16 98 104 I-clinical_variable
load 17 21 105 109 I-clinical_variable
< 22 23 110 111 O
24 23 25 111 113 B-upper_bound
hours 26 31 114 119 I-upper_bound
prior 32 37 120 125 I-upper_bound
to 38 40 126 128 O
procedure 41 50 129 138 O
( 51 52 139 140 O
major 52 57 140 145 O
confounder 58 68 146 156 O
that 69 73 157 161 O
is 74 76 162 164 O
known 77 82 165 170 O
to 83 85 171 173 O
reduce 86 92 174 180 O
inflammatory 93 105 181 193 B-clinical_variable
levels 106 112 194 200 I-clinical_variable
in 113 115 201 203 O
12 116 118 204 206 B-lower_bound
to 119 121 207 209 O
24 122 124 210 212 O
hours 125 130 213 218 O
) 130 131 218 219 O

History 0 7 220 227 O
of 8 10 228 230 O
colchicine 11 21 231 241 B-treatment
intolerance 22 33 242 253 O

History 0 7 254 261 O
of 8 10 262 264 O
myelodysplasia 11 25 265 279 B-cancer
( 26 27 280 281 O
due 27 30 281 284 O
to 31 33 285 287 O
suggested 34 43 288 297 O
cautionary 44 54 298 308 O
use 55 58 309 312 O
of 59 61 313 315 O
colchicine 62 72 316 326 B-treatment
in 73 75 327 329 O
this 76 80 330 334 O
setting 81 88 335 342 O
) 88 89 342 343 O

Referred 0 8 344 352 O
for 9 12 353 356 O
possible 13 21 357 365 O
PCI 22 25 366 369 B-treatment

Use 0 3 370 373 O
of 4 6 374 376 O
anti 7 11 377 381 B-treatment
- 11 12 381 382 I-treatment
inflammatory 12 24 382 394 I-treatment
agents 25 31 395 401 I-treatment

Use 0 3 402 405 O
of 4 6 406 408 O
strong 7 13 409 415 O
Cytochrome 14 24 416 426 B-treatment
P450 25 29 427 431 I-treatment
, 29 30 431 432 O
Family 31 37 433 439 B-treatment
3 38 39 440 441 I-treatment
, 39 40 441 442 O
Subfamily 41 50 443 452 B-treatment
A 51 52 453 454 I-treatment
, 52 53 454 455 O
Polypeptide 54 65 456 467 B-treatment
4 66 67 468 469 I-treatment
( 68 69 470 471 I-treatment
CYP3A4 69 75 471 477 I-treatment
) 75 76 477 478 I-treatment
and/or 77 83 479 485 O
P 84 85 486 487 B-treatment
- 85 86 487 488 I-treatment
glycoprotein 86 98 488 500 I-treatment
inhibitors 99 109 501 511 I-treatment

aspirin 0 7 512 519 B-treatment

clarithromycin 0 14 520 534 B-treatment

cyclosporine 0 12 535 547 B-treatment

diltiazem 0 9 548 557 B-treatment

infection 0 9 558 567 B-chronic_disease
( 10 11 568 569 O
major 11 16 569 574 O
confounder 17 27 575 585 O
with 28 32 586 590 O
increased 33 42 591 600 O
inflammatory 43 55 601 613 O
markers 56 63 614 621 O
) 63 64 621 622 O

ketoconazole 0 12 623 635 B-treatment

on 0 2 636 638 O
dialysis 3 11 639 647 B-treatment
( 12 13 648 649 O
due 13 16 649 652 O
to 17 19 653 655 O
the 20 23 656 659 O
need 24 28 660 664 O
to 29 31 665 667 O
adjust 32 38 668 674 O
colchicine 39 49 675 685 B-treatment
dose 50 54 686 690 O
in 55 57 691 693 O
this 58 62 694 698 O
setting 63 70 699 706 O
) 70 71 706 707 O

ritonavir 0 9 708 717 B-treatment

verapamil 0 9 718 727 B-treatment

within 0 6 728 734 O
5 7 8 735 736 B-upper_bound
halflives 9 18 737 746 I-upper_bound
of 19 21 747 749 O
the 22 25 750 753 O
individual 26 36 754 764 O
drug 37 41 765 769 O

